TSN Stock Analysis: Tyson Foods | NYSE
Farm Products | NYSE, USA | Market Cap: 18.255m USD | 12M Return: 3.4% | US9024941034 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 173M
EPS Trend: 87.1%
Qual. Beats: 0
Rev. Trend: 95.8%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Tyson Foods (NYSE: TSN) is a U.S.-headquartered, multinational food company that operates across four core segments: Beef, Pork, Chicken, and Prepared Foods. The company runs a vertically integrated protein business, processing live cattle and hogs into primal and sub-primal cuts and ready-to-cook meats, raising and processing chickens into fresh, frozen, and value-added poultry products, and producing a broad portfolio of branded refrigerated and frozen foods such as sandwiches, bacon, sausage, lunchmeats, hot dogs, and ethnic or snack items. Its portfolio includes well-known consumer brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, Gallo Salame, ibp, and State Fair.
The company distributes through a multi-channel network spanning grocery retailers and wholesalers, warehouse clubs, military commissaries, chain restaurants and their distributors, international exporters, food-service operators (such as schools, hospitals, and convenience stores), and independent brokers. Founded in 1935, Tyson is based in Springdale, Arkansas, and is classified within the Consumer Staples sector under the Packaged Foods & Meats sub-industry. As one of the largest protein producers in the United States, Tyson benefits from scale advantages in livestock sourcing, processing capacity, and refrigerated supply-chain logistics, and its diversified mix of commodity meat production and higher-margin prepared foods helps balance exposure to volatile input costs and shifting consumer protein preferences.
- Beef segment margins compress on elevated cattle costs
- Chicken pricing recovers as feed costs ease
- Prepared Foods revenue grows on Jimmy Dean and Hillshire demand
| Net Income: 574.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.30 > 1.0 |
| NWC/Revenue: 5.14% < 20% (prev 7.70%; Δ -2.56% < -1%) |
| CFO/TA 0.06 > 3% & CFO 2.00b > Net Income 574.0m |
| Net Debt (7.27b) to EBITDA (2.60b): 2.79 < 3 |
| Current Ratio: 1.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (350.0m) vs 12m ago 0.57% < -2% |
| Gross Margin: 6.16% > 18% (prev 7.20%; Δ -1.04% > 0.5%) |
| Asset Turnover: 154.5% > 50% (prev 148.5%; Δ 6.05% > 0%) |
| Interest Coverage Ratio: 3.0 > 6 (EBIT TTM 1.22b / Interest Expense TTM 405.0m) |
| A: 0.08 (Total Current Assets 9.46b - Total Current Liabilities 6.60b) / Total Assets 35.6b |
| B: 0.52 (Retained Earnings 18.6b / Total Assets 35.6b) |
| C: 0.03 (EBIT TTM 1.22b / Avg Total Assets 36.0b) |
| D: 1.04 (Book Value of Equity 18.1b / Total Liabilities 17.4b) |
| Altman-Z'' = 3.55 = A |
| DSRI: 0.97 (Receivables 2.46b/2.45b, Revenue 55.7b/54.1b) |
| GMI: 1.17 (GM 7.20% / 6.16%) |
| AQI: 1.01 (AQ_t 0.49 / AQ_t-1 0.48) |
| SGI: 1.03 (Revenue 55.7b / 54.1b) |
| TATA: -0.04 (NI 574.0m - CFO 2.00b) / TA 35.6b) |
| Beneish M = -2.87 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 52.34 with a total of 3,757,502 shares traded. Over the past week, the price has changed by +3.71%, over one month by +0.11%, over three months by -9.38% and over the past year by +3.36%.
Current recommended Stop Loss: 51.00 (which is 2.6% or 1.3 ATR below the current price).
Tyson Foods has received a consensus analysts rating of 3.46. Therefore, it is recommended to hold TSN.
- StrongBuy: 2
- Buy: 3
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 64.3 | 22.8% |
P/E Trailing = 32.0309
P/E Forward = 11.2233
P/S = 0.3278
P/B = 1.0084
P/EG = 1.0438
Revenue TTM = 55.7b USD
EBIT TTM = 1.22b USD
EBITDA TTM = 2.60b USD
Long Term Debt = 6.58b USD (from longTermDebt, last quarter)
Short Term Debt = 1.43b USD (from shortTermDebt, last quarter)
Debt = 8.01b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.27b USD (calculated: Debt 8.01b - CCE 740.0m)
Enterprise Value = 25.5b USD (18.3b + Debt 8.01b - CCE 740.0m)
Interest Coverage Ratio = 3.0 (Ebit TTM 1.22b / Interest Expense TTM 405.0m)
EV/FCF = 21.98x (Enterprise Value 25.5b / FCF TTM 1.16b)
FCF Yield = 4.55% (FCF TTM 1.16b / Enterprise Value 25.5b)
FCF Margin = 2.08% (FCF TTM 1.16b / Revenue TTM 55.7b)
Net Margin = 1.03% (Net Income TTM 574.0m / Revenue TTM 55.7b)
Gross Margin = 6.16% ((Revenue TTM 55.7b - Cost of Revenue TTM 52.3b) / Revenue TTM)
Gross Margin QoQ = 6.64% (prev 7.05%)
Tobins Q-Ratio = 0.72 (Enterprise Value 25.5b / Total Assets 35.6b)
Interest Expense / Debt = 5.06% (Interest Expense 405.0m / Debt 8.01b)
Taxrate = 27.07% (222.0m / 820.0m)
NOPAT = 886.1m (EBIT 1.22b * (1 - 27.07%))
Current Ratio = 1.43 (Total Current Assets 9.46b / Total Current Liabilities 6.60b)
Debt / Equity = 0.44 (Debt 8.01b / totalStockholderEquity, last quarter 18.1b)
Debt / EBITDA = 2.79 (Net Debt 7.27b / EBITDA 2.60b)
Debt / FCF = 6.26 (Net Debt 7.27b / FCF TTM 1.16b)
Total Stockholder Equity = 18.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.59% (Net Income 574.0m / Total Assets 35.6b)
RoE = 3.18% (Net Income TTM 574.0m / Total Stockholder Equity 18.1b)
RoCE = 4.93% (EBIT 1.22b / Capital Employed (Equity 18.1b + L.T.Debt 6.58b))
RoIC = 2.98% (NOPAT 886.1m / Invested Capital 29.7b)
WACC = 5.27% (E(18.3b)/V(26.3b) * Re(5.96%) + D(8.01b)/V(26.3b) * Rd(5.06%) * (1-Tc(0.27)))
Discount Rate = 5.96% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -62.89 | Cagr: -0.63%
[DCF] Terminal Value 73.87% ; FCFF base≈1.22b ; Y1≈1.11b ; Y5≈978.5m
[DCF] Fair Price = 29.37 (EV 15.5b - Net Debt 7.27b = Equity 8.28b / Shares 281.8m; r=8.35% [WACC [floored]]; 5y FCF grow -10.55% → 2.50% )
EPS Correlation: 87.12 | EPS CAGR: 55.23% | SUE: -0.41 | # QB: 0
Revenue Correlation: 95.84 | Revenue CAGR: 2.11% | SUE: -0.92 | # QB: -1
EPS current Quarter (2026-12-31): EPS=1.01 | Chg30d=-8.85% | Revisions=-62% | Analysts=7
EPS current Year (2026-09-30): EPS=3.71 | Chg30d=-6.19% | Revisions=-44% | GrowthEPS=-10.1% | GrowthRev=+3.4%
EPS next Year (2027-09-30): EPS=4.13 | Chg30d=-7.82% | Revisions=+0% | GrowthEPS=+11.4% | GrowthRev=-1.3%
[Analyst] Revisions Ratio: -41% (up=5, down=14)